PVI

Pura Vida Investments Portfolio holdings

AUM $16.6M
This Quarter Return
+10.13%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.45B
AUM Growth
+$1.45B
Cap. Flow
+$181M
Cap. Flow %
12.5%
Top 10 Hldgs %
32.03%
Holding
256
New
67
Increased
49
Reduced
31
Closed
33

Top Buys

1
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$30.8M
2
APR
Apria, Inc. Common Stock
APR
$21.4M
3
ALGN icon
Align Technology
ALGN
$19M
4
NTLA icon
Intellia Therapeutics
NTLA
$15.2M
5
CUTR
Cutera, Inc.
CUTR
$15M

Top Sells

1
VCEL icon
Vericel Corp
VCEL
$17.6M
2
AFIB
Acutus Medical, Inc. Common Stock
AFIB
$13.5M
3
SHC icon
Sotera Health
SHC
$12.9M
4
OPCH icon
Option Care Health
OPCH
$12.1M
5
HAE icon
Haemonetics
HAE
$9.8M

Sector Composition

1 Healthcare 80.26%
2 Industrials 3.49%
3 Materials 1.12%
4 Financials 1.09%
5 Consumer Staples 0.93%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SPKBU
76
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
$4.72M 0.13%
+475,000
New +$4.72M
CMAX
77
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$4.45M 0.13%
367,014
+4,399
+1% +$53.4K
SNCE
78
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.44M 0.13%
438,111
+38,111
+10% +$386K
ACRS icon
79
Aclaris Therapeutics
ACRS
$223M
$4.43M 0.13%
175,799
+125,799
+252% +$3.17M
ARQT icon
80
Arcutis Biotherapeutics
ARQT
$1.91B
$4.22M 0.12%
+145,744
New +$4.22M
SOLY
81
DELISTED
Soliton, Inc.
SOLY
$4.18M 0.12%
+237,650
New +$4.18M
NAUT icon
82
Nautilus Biotechnolgy
NAUT
$80.7M
$4.07M 0.12%
+295,554
New +$4.07M
CMPS
83
Compass Pathways
CMPS
$452M
$3.98M 0.11%
108,146
+5,152
+5% +$190K
FBRX icon
84
Forte Biosciences
FBRX
$138M
$3.89M 0.11%
113,466
+48,466
+75% +$1.66M
EPIX icon
85
ESSA Pharma
EPIX
$11.2M
$3.85M 0.11%
132,483
+22,334
+20% +$649K
KURA icon
86
Kura Oncology
KURA
$732M
$3.51M 0.1%
124,240
+48,440
+64% +$1.37M
MRNA icon
87
Moderna
MRNA
$9.36B
$3.51M 0.1%
+26,791
New +$3.51M
BFLY.WS icon
88
Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
BFLY.WS
$11.1M
$3.44M 0.1%
+533,372
New +$3.44M
CLDX icon
89
Celldex Therapeutics
CLDX
$1.57B
$3.37M 0.1%
+163,615
New +$3.37M
CFMS
90
DELISTED
Conformis, Inc. Common Stock
CFMS
$3.36M 0.1%
+3,396,043
New +$3.36M
GILD icon
91
Gilead Sciences
GILD
$140B
$3.27M 0.09%
+50,602
New +$3.27M
TVTX icon
92
Travere Therapeutics
TVTX
$1.75B
$3.16M 0.09%
+126,533
New +$3.16M
BFLY icon
93
Butterfly Network
BFLY
$378M
$3.09M 0.09%
183,765
-101,235
-36% -$1.7M
FRONU
94
DELISTED
Frontier Acquisition Corp. Units
FRONU
$2.98M 0.08%
+300,000
New +$2.98M
MTACU
95
DELISTED
MedTech Acquisition Corporation Unit
MTACU
$2.92M 0.08%
290,047
-459,953
-61% -$4.62M
VINC
96
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2.89M 0.08%
149,516
+5,501
+4% +$106K
MIST icon
97
Milestone Pharmaceuticals
MIST
$151M
$2.71M 0.08%
467,640
+17,640
+4% +$102K
FNCH
98
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2.58M 0.07%
+160,000
New +$2.58M
ZNTL icon
99
Zentalis Pharmaceuticals
ZNTL
$123M
$2.46M 0.07%
+56,776
New +$2.46M
ABGI
100
DELISTED
ABG Acquisition Corp. I Class A Ordinary Shares
ABGI
$2.44M 0.07%
+246,507
New +$2.44M
2 3
4
5 6